Get started
Libratus

CRSP- Pioneer and leader in gene editing

CRISPR Therapeutics AG (NASDAQ:CRSP)  
Libratus  
NASDAQ:CRSP   CRISPR Therapeutics AG
Trend Analysis Technical Indicators Fundamental Analysis CRSP crspr geneediting EDIT NTLA beam
2
0
trendanalysis indicator fundamental crsp crspr geneediting edit ntla beam
CRSP is the leader and pioneer of the CRISPR/CAS9 gene-editing breakthrough. It is a long-term bet as short-term to mid-term future is uncertain.

I think it has one more leg down. Accumulate in the demand zone.

Related Ideas

Libratus
ILMN- Leader in gene sequencing
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.